Outcome of Bariatric Surgery in Patients with Unexpected Liver Cirrhosis: A Multicenter Study from China

Overview

Journal Liver Res

Date 2025 Feb 17

PMID 39957746

Authors

Xia Sun

Libin Yao

Xing Kang

Weihua Yu

Fidele Kakule Kitaghenda

Mohammad Sajjad Ibn Rashid

Angeline Nogue Taguemkam

Jian Hong

Zhiyong Dong

Xitai Sun

Xiaocheng Zhu

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Liver cirrhosis is a complex disease that may result in increased morbidity and mortality following bariatric surgery (BS). This study aimed to explore the outcome of BS in patients with unexpected cirrhosis, focusing on postoperative complications and the progression of liver disease.

Methods: A retrospective study of bariatric patients with cirrhosis from four centers in China between 2016 and 2023 was conducted, with follow-up for one year after BS. The primary outcome was the safety of BS in patients with unexpected cirrhosis, while the secondary outcome was the metabolic efficacy of BS in this group postoperatively.

Results: A total of 47 patients met the study criteria, including 46 cases of Child-Pugh class A cirrhosis and 1 case of Child-Pugh B. Pathological examination confirmed nodular cirrhosis in 21 patients (44.68%), pseudolobule formation in 1 patient (2.13%), lipedema degeneration with inflammatory cell infiltration in 3 patients (6.38%), and chronic hepatitis in 1 patient (2.13%). The average percentage of total weight loss was 29.73 ± 6.53% at one year postoperatively. During the 30-day postoperative period, the complication rate was 6.38%, which included portal vein thrombosis, gastrointestinal bleeding, and intra-abdominal infection. Moreover, no cases of liver decompensation or mortality were reported during the follow-up period. The remission rates of comorbidities among 41 patients one year after surgery were as follows: dyslipidemia 100%, type 2 diabetes 82.61%, hypertension 84.62%, and obstructive sleep apnea syndrome 85.71%.

Conclusions: BS can be safely performed in patients with unexpected cirrhosis in the compensated stage of liver disease, with low postoperative morbidity and no mortality observed during one-year follow-up.

References

Mumtaz K, Lipshultz H, Jalil S, Porter K, Li N, Kelly S . Bariatric Surgery in Patients with Cirrhosis: Careful Patient and Surgery-Type Selection Is Key to Improving Outcomes. Obes Surg. 2020; 30(9):3444-3452. DOI: 10.1007/s11695-020-04583-4. View

Widjaja J, Sun X, Chu Y, Hong J, Yao L, Zhu X . Sleeve Gastrectomy with Braun Anastomosis Transit Bipartition (B-TB): a Potential Midway Between Single Anastomosis and Roux-en-Y Transit Bipartition. Obes Surg. 2021; 31(12):5500-5503. DOI: 10.1007/s11695-021-05756-5. View

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

Pestana L, Swain J, Dierkhising R, Kendrick M, Kamath P, Watt K . Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience. Mayo Clin Proc. 2015; 90(2):209-15. DOI: 10.1016/j.mayocp.2014.11.012. View

Manzano-Nunez R, Rivera-Esteban J, Comas M, Angel M, Flores V, Banares J . Outcomes of Patients with Severe Obesity and Cirrhosis with Portal Hypertension Undergoing Bariatric Surgery: a Systematic Review. Obes Surg. 2022; 33(1):224-233. DOI: 10.1007/s11695-022-06362-9. View

Carlin A, Varban O, Ehlers A, Bonham A, Ghaferi A, Finks J . Independent predictors and timing of portomesenteric vein thrombosis after bariatric surgery. Surg Obes Relat Dis. 2022; 18(12):1385-1391. DOI: 10.1016/j.soard.2022.07.016. View

Schauer P, Ikramuddin S . Laparoscopic surgery for morbid obesity. Surg Clin North Am. 2001; 81(5):1145-79. DOI: 10.1016/s0039-6109(05)70189-4. View

Huang S, Liu C . Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives. Clin Mol Hepatol. 2023; 29(2):320-331. PMC: 10121303. DOI: 10.3350/cmh.2022.0422. View

Rouhi A, Castle R, Hoeltzel G, Williams N, Dumon K, Baimas-George M . Sleeve Gastrectomy Reduces the Need for Liver Transplantation in Patients with Obesity and Non-Alcoholic Steatohepatitis: a Predictive Model. Obes Surg. 2024; 34(4):1224-1231. DOI: 10.1007/s11695-024-07102-x. View

10.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2017; 41(Suppl 1):S13-S27. DOI: 10.2337/dc18-S002. View

11.

Mosko J, Nguyen G . Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011; 9(10):897-901. DOI: 10.1016/j.cgh.2011.07.007. View

12.

Wu Y, Peng X, Zhu Y, Yan X, Chen W, Lin X . Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein. J Virol. 2015; 90(4):1729-40. PMC: 4733992. DOI: 10.1128/JVI.02604-15. View

13.

Minambres I, Rubio M, de Hollanda A, Breton I, Vilarrasa N, Pellitero S . Outcomes of Bariatric Surgery in Patients with Cirrhosis. Obes Surg. 2018; 29(2):585-592. DOI: 10.1007/s11695-018-3562-8. View

14.

Ibrahim M, Elshennawy A, Wassef A, Salah A, Hassan A, Mikhail S . One Anastomosis Gastric Bypass Versus Long Biliopancreatic Limb Roux-en-Y Gastric Bypass. Obes Surg. 2022; 32(3):779-785. PMC: 8866326. DOI: 10.1007/s11695-021-05874-0. View

15.

Ahmed S, Pouwels S, Parmar C, Kassir R, De Luca M, Graham Y . Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review. Obes Surg. 2021; 31(5):2255-2267. DOI: 10.1007/s11695-021-05289-x. View

16.

Li R, Shen M, Ong J, Cui F, Hu W, Chan P . Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Rep. 2023; 5(10):100833. PMC: 10477682. DOI: 10.1016/j.jhepr.2023.100833. View

17.

Wijarnpreecha K, Pungpapong S, Aby E, Croome K, Taner C, Thompson C . Simultaneous liver transplant and sleeve gastrectomy not associated with worse index admission outcomes compared to liver transplant alone - a retrospective cohort study. Transpl Int. 2020; 33(11):1447-1452. DOI: 10.1111/tri.13713. View

18.

Liu Z, Lin C, Mao X, Guo C, Suo C, Zhu D . Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023; 72(12):2354-2363. PMC: 10715530. DOI: 10.1136/gutjnl-2023-330691. View

19.

Musso G, Gambino R, Cassader M . Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2008; 48(1):1-26. DOI: 10.1016/j.plipres.2008.08.001. View

20.

Zhao Y, Ye Z, Lin J, Zhang Z, Tian P, Zhang Z . Efficacy and Safety of Pharmacoprophylaxis for Venous Thromboembolism in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg. 2022; 32(5):1701-1718. DOI: 10.1007/s11695-021-05825-9. View